Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

Published: March 31 2015
Abstract Views: 2466
PDF: 2238
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- F. Schiavon, M. Favero, V. Carraro, L. Riato, Septic arthritis: what is the role for the rheumatologist? , Reumatismo: Vol. 60 No. 1 (2008)
- P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco, MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica , Reumatismo: Vol. 61 No. 2 (2009)
- S.L. Bello, L. Serafino, C. Bonali, N. Terlizzi, C. Fanizza, C. Anecchino, G. Lapaldula, Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents , Reumatismo: Vol. 64 No. 5 (2012)
- S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini, The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation , Reumatismo: Vol. 67 No. 2 (2015)
- S. D'Angelo, C. Palazzi, I. Olivieri, Psoriatic arthritis: treatment strategies using biologic agents , Reumatismo: Vol. 64 No. 2 (2012)
- N. Maruotti, A. Corrado, F.P. Cantatore, Osteoporosis and rheumatic diseases , Reumatismo: Vol. 66 No. 2 (2014)
- A. Marchesoni, F. Cantini, Classification and clinical assessment , Reumatismo: Vol. 64 No. 2 (2012)
- D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes, Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series , Reumatismo: Vol. 76 No. 4 (2024)
- G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta, GISEA: an Italian biological agents registry in rheumatology , Reumatismo: Vol. 63 No. 3 (2011)
- I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia, The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis , Reumatismo: Vol. 74 No. 4 (2022)
1-10 of 530
Next
You may also start an advanced similarity search for this article.